Chloride Channels - New Targets for the Prevention of Stroke

Yan-Hua Du, Yong-Yuan Guan1

  • 1Department of Pharmacology, Cardiac & Cerebral Vascular Research Center, Zhongshan School of Medicine, Sun Yat-Sen University, 74 Zhongshan 2 Rd, Guangzhou, 510080, P. R. China. guanyy@mail.sysu.edu.cn.

Insights

Hypertension alters chloride channels in brain blood vessels, increasing stroke risk. Targeting these channels, like volume-regulated Cl(-) channels (VRCC) and calcium-activated Cl- channels (CaCC), may offer new stroke prevention strategies.

Area of Science:

  • Neuroscience
  • Cardiovascular Biology
  • Molecular Physiology

Background:

  • Stroke is a major global health concern, with hypertension-induced cerebrovascular remodeling being a key risk factor.
  • Cerebral vascular smooth muscle cells (VSMC) utilize volume-regulated Cl(-) channels (VRCC) and calcium-activated Cl- channels (CaCC) for crucial functions.
  • Hypertension is associated with altered activity of these chloride channels in VSMC.

Purpose of the Study:

  • To review recent findings on the roles of VRCC and CaCC in VSMC during hypertension.
  • To explore the involvement of these channels in cellular processes contributing to cerebrovascular remodeling.
  • To discuss potential therapeutic targets for stroke prevention related to chloride channels.

Main Methods:

  • Review of current scientific literature on chloride channels (ClC-3 and TMEM16A) in VSMC.
  • Analysis of studies investigating channel function in the context of hypertension and cerebrovascular remodeling.
  • Examination of the relationship between channel activity and stroke prevention agents.

Main Results:

  • ClC-3 is identified as a likely VRCC, and TMEM16A as the CaCC in brain VSMC.
  • VRCC activity increases, while CaCC activity decreases in cerebral VSMC with escalating hypertension.
  • These chloride channels influence VSMC proliferation, apoptosis, inflammation, and oxidative stress.

Conclusions:

  • Altered VRCC and CaCC activity in VSMC are implicated in hypertension-related cerebrovascular remodeling and stroke risk.
  • Chloride channels represent promising novel therapeutic targets for stroke prevention.
  • Further research into VRCC and CaCC modulation could lead to new clinical strategies.

Related Concept Videos

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
4.2K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
11.3K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
1.0K
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
11.1K
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

7.5K